Ellen Rosenberg
General Counsel bei AMICUS THERAPEUTICS, INC.
Vermögen: 4 Mio $ am 30.04.2024
Profil
Ellen Stacy Rosenberg is currently the Secretary & Chief Legal Officer at Amicus Therapeutics, Inc. She previously worked as a Secretary at NPS Pharmaceuticals, Inc. and as a Secretary & Senior Vice President at Shire ViroPharma, Inc. from 2007 to 2015.
Before that, she was the Associate General Counsel-Metabolic Endocrinology at EMD Serono, Inc. from 1999 to 2007.
She also served as the Senior Vice President & Associate General Counsel at Shire Pharmaceuticals, Inc. from 2007 to 2015.
Ms. Rosenberg obtained her undergraduate degree from the University of Connecticut and her graduate degree from The University of Pennsylvania Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.02.2024 | 382 654 ( 0,13% ) | 4 Mio $ | 30.04.2024 |
Aktive Positionen von Ellen Rosenberg
| Unternehmen | Position | Beginn |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | General Counsel | 10.02.2016 |
Ehemalige bekannte Positionen von Ellen Rosenberg
| Unternehmen | Position | Ende |
|---|---|---|
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Unternehmenssekretär | 01.05.2015 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01.05.2015 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.01.2007 |
| NPS PHARMACEUTICALS, INC. | Unternehmenssekretär | - |
Ausbildung von Ellen Rosenberg
| University of Connecticut | Undergraduate Degree |
| The University of Pennsylvania Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
